
Hear Jeff Elton talk about the future of personalized medicine, and why you need to be at the MassBio Annual meeting.
Former Merck CEO Raymond Gilmartin and three other leaders share their approaches to testing strategy.
Clayton Christensen beat a heart attack, advanced-stage cancer and a stroke in three years. Here's what he learned about life, death and fixing the health care system.
A new cancer care startup called KEW Group has been quietly operating in the Boston area and entered advanced talks to raise a sizable amount from venture investors.
Researchers are developing more and more genetic tests for specific cancers, but doctors don't use them as often as they should—a new network of clinics aims to change that.
Phacilitate’s Leaders’ Forum is the event for the highest levels of R&D management from across the global life sciences sector with conferences dedicated to Oncology and CNS. Its interactive program focuses on how to improve productivity, quality and efficiency at all stages of the drug discovery and development pipeline.